Börsen-Live-Ticker
Fort Technology Announces AGSM Results
Toronto, Ontario, Aug. 28, 2026 (GLOBE NEWSWIRE) -- Fort Technology Inc. (NASDAQ: FRTT; TSXV: FORT) (“Fort” or the “Company”), is pleased t
Cosmos Health Strengthens Balance Sheet and Streamlines Capital Structure; Retires $8M ATW Convertible Note One Year Ahead of Maturity, Eliminating Further Dilution From Conversions
$8 million senior secured ATW convertible note satisfied, together with all accrued interest, twelve months ahead of its August 2027 maturity
Sustainable Innovation & Health Dividend Fund Normal Course Issuer Bid
TORONTO, Aug. 28, 2026 (GLOBE NEWSWIRE) -- Sustainable Innovation & Health Dividend Fund (the “Fund”) (TSX: SIH.UN) announced that it ha
Lucas GC Limited Announces Effective Date of Share Consolidation
NEW YORK, Aug. 28, 2026 (GLOBE NEWSWIRE) -- Lucas GC Limited (NASDAQ: LGCL) (“Lucas” or the “Company”), an artificial intelligence (the “AI”
Northrim BanCorp, Inc. Declares Quarterly Cash Dividend of $0.17 per Share
ANCHORAGE, Alaska, Aug. 28, 2026 (GLOBE NEWSWIRE) -- Northrim BanCorp, Inc. (NASDAQ: NRIM) today announced that the Board of Directors decla
Air Canada Takes Additional Measures to Make Travel Easier for Customers Travelling with Mobility Aids
Customers can now travel complimentary with up to three mobility aidsNew policy gives customers greater flexibility and consistency when trave
ASUS Announces Availability of the Chromebook CM32 Detachable for Business and Education
Fremont, CA, Aug. 28, 2026 (GLOBE NEWSWIRE) -- ASUS, a global technology leader that provides the world's most innovative and intuitive devi
Vivos Therapeutics and South Palm Cardiovascular Associates Sign Definitive Agreements to Launch Regional Sleep Testing and Treatment Center
LITTLETON, Colo., Aug. 28, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. ("Vivos" or "the Company") (Nasdaq: VVOS), a leading medical de
Change Agents Accepted into Seagate Partner Program, Expanding Access to AI Infrastructure Ecosystem
FREEHOLD, N.J., Aug. 28, 2026 (GLOBE NEWSWIRE) -- Change Agents Corporation (Nasdaq: CHGA) (“Change Agents” or the “Company”), a developer o
Amaero Announces Results of Special Meeting of Stockholders
MCDONALD, Tenn., Aug. 28, 2026 (GLOBE NEWSWIRE) -- Amaero Inc. (ASX:3DA) (“Amaero” or the “Company”), a leading U.S. domestic producer of hi
Wellchange Holdings Company Limited Announces Pricing of $7.5 Million Public Offering of its Class A Ordinary Shares
Hong Kong, Aug. 28, 2026 (GLOBE NEWSWIRE) -- Wellchange Holdings Company Limited (NASDAQ: WCT) (“Company” or “Wellchange”), an enterprise s
FangDD Reports First Half 2026 Unaudited Financial Results
SHENZHEN, China, Aug. 28, 2026 (GLOBE NEWSWIRE) -- Fangdd Network Group Ltd. (NASDAQ: DUO) (“FangDD” or “the Company”), a customer-oriented
XTEND Delivers Hundreds of M6F Tactical ISR Systems to Asia-Pacific Defense Customer
Lightweight system weighing less than two kilograms supports indoor and outdoor intelligence, surveillance and reconnaissance operations at th
INVO Fertility to Participate in H.C. Wainwright's 28th Annual Global Investment Conference
SARASOTA, Fla., Aug. 28, 2026 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) ("INVO Fertility" or the "Company"), a healthcare ferti
Aprea Therapeutics Announces Expansion of Intellectual Property Portfolio for Precision Oncology Programs
DOYLESTOWN, Pa., Aug. 28, 2026 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage pre
SAIC Board of Directors Declares Cash Dividend
RESTON, Va., Aug. 28, 2026 (GLOBE NEWSWIRE) -- Science Applications International Corp. (NASDAQ: SAIC) announced today that the company’s bo
New REDUCE-IT® Legacy Analysis Presented at European Society of Cardiology (ESC) Congress 2026 Suggests Persistent Cardiovascular Benefit Following Icosapent Ethyl Treatment Cessation in Adherent Patients
DUBLIN and BRIDGEWATER, N.J., Aug. 28, 2026 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a company committed to advancing the s
Broader Defense Platform Takes Shape as NAPC Defense Builds Momentum Under New NAPD Identity
CLEARWATER, Fla., Aug. 28, 2026 (GLOBE NEWSWIRE) -- NAPC Defense, Inc. (OTCID: NAPD) (“NAPC Defense” or the “Company”), a U.S.-licensed defe
Glucose Health, Inc. (OTCID: GLUC) Appoints Consumer Products Industry Veteran John Duffy as Chief Executive Officer to Accelerate Growth, Elevate Brand Leadership, and Maximize Long-Term Shareholder Value
BENTONVILLE, Ark., Aug. 28, 2026 (GLOBE NEWSWIRE) -- Glucose Health, Inc. (OTCID: GLUC) ("Glucose Health" or the "Company"), a consumer heal
3D Seismic Defines Multiple High-Priority Helium Drill Targets at Montana West Butte Project
KELOWNA, British Columbia, Aug. 28, 2026 (GLOBE NEWSWIRE) -- REV Exploration Corp. (“REV” or the “Company”) (TSXV: REVX; OTCID: REVFF) is pl
ENvue Medical, Inc. Announces 1-for-12 Reverse Stock Split
TYLER, Texas, Aug. 28, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ: FEED) ("ENvue" or the "Company"), a commercial-stage medical te
Black Rock Coffee Bar Continues Expansion in Arizona with new Tucson Location
Scottsdale, AZ, Aug. 28, 2026 (GLOBE NEWSWIRE) -- Black Rock Coffee Bar, the Oregon-born boutique coffee company known for its specialty cof
Minerva Neurosciences to Participate in Two Upcoming Investor Conferences
BURLINGTON, Mass., Aug. 28, 2026 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company
Core AI Holdings Reports 56% Q2 Revenue Growth and Significant Improvement in Gross Margin
MIAMI, FL, Aug. 28, 2026 (GLOBE NEWSWIRE) -- Core AI Holdings, Inc. (Nasdaq: CHAI) (“Core AI” or the “Company”), a global AI technology and
Hecate Energy and EGH Acquisition Corp. Provide Update on Path to Planned Nasdaq Listing and Progress Toward Business Combination
Hecate and EGH confirm progress toward Hecate’s planned Nasdaq listing under the ticker “HCTE” and update the expected closing timeline follow
Mobia Medical Announces Addition of Paired VNS to Updated AHA Stroke Guidelines
AUSTIN, Texas, Aug. 28, 2026 (GLOBE NEWSWIRE) -- Mobia Medical, Inc. (Nasdaq: MOBI), a medical device company redefining stroke recovery for
Calian Announces Normal Course Issuer Bid and Filing of Short Form Base Shelf Prospectus
OTTAWA, Ontario, Aug. 28, 2026 (GLOBE NEWSWIRE) -- Calian Group Ltd. (“Calian” or the “Company”) (TSX: CGY) is pleased to announce that the
Golconda Gold Releases Financial and Operating Results for Q2 2026
TORONTO, Aug. 28, 2026 (GLOBE NEWSWIRE) -- Golconda Gold Ltd. (“Golconda Gold” or the “Company”) (TSX-V: GG; OTCQX: GGGOF) is pleased to ann
GURU Organic Energy to Report Third Quarter 2026 Results
MONTREAL, Aug. 28, 2026 (GLOBE NEWSWIRE) -- GURU Organic Energy Corp. (TSX: GURU) (“GURU” or the “Company”), Canada’s leading organic energy
SalesCloser Reports Third Quarter Fiscal 2026 Financial Results and Recent Business Highlights
Revenue grew 90% year-over-year in Q3 Fiscal 2026 to $367,083, and 235% year-over-year on a nine-month basis to $1,129,858, with gross margin
Chagee Announces Second Quarter 2026 Unaudited Financial Results
SHANGHAI, Aug. 28, 2026 (GLOBE NEWSWIRE) -- Chagee Holdings Limited (NASDAQ: CHA) (“Chagee” or the “Company”), a leading premium tea drinks
Arianne Phosphate Announces Results of Its Annual General Meeting
SAGUENAY, Quebec, Aug. 28, 2026 (GLOBE NEWSWIRE) -- Arianne Phosphate (the “Company” or “Arianne”) (TSX VENTURE: DAN; OTCQB: DRRSF; FRANKFUR
XORTX Announces Termination and Postponement of Investor Relations Program
CALGARY, Alberta, Aug. 28, 2026 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) NASDAQ: XRTX | TSXV: XRTX | Frankfurt
iBio Reports Fiscal Year 2026 Financial Results and Provides Corporate Update
SAN DIEGO, Aug. 28, 2026 (GLOBE NEWSWIRE) -- iBio, Inc. (NASDAQ: IBIO), a clinical-stage biotechnology company developing long-acting antibo
Globaltech Reports Second Quarter 2026 Revenue of $11.1 Million, Up 98% Year Over Year
RENO, Nev., Aug. 28, 2026 (GLOBE NEWSWIRE) -- Globaltech Corporation (OTCQB: GLTK) (“Globaltech” or the “Company”), a publicly-traded techno
Questor Announces Second Quarter Results
CALGARY, Alberta, Aug. 28, 2026 (GLOBE NEWSWIRE) -- Questor Technology Inc. (“Questor” or the “Company”) (TSX-V: QST) announced today its fi
MoneyHero Group to Announce Second Quarter 2026 Results
HONG KONG and SINGAPORE, Aug. 28, 2026 (GLOBE NEWSWIRE) -- MoneyHero Limited (Nasdaq: MNY) (“MoneyHero” or the “Company”), a leading tech- a
Avricore Grants Options
VANCOUVER, British Columbia, Aug. 28, 2026 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) today announces that the Company’s board of
G Mining Ventures Announces Normal Course Issuer Bid for Common Shares
BROSSARD, Quebec, Aug. 28, 2026 (GLOBE NEWSWIRE) -- G Mining Ventures Corp. (“GMIN” or the “Corporation”) (TSX: GMIN, OTCQX: GMINF) is pleas
Range Declares Quarterly Dividend
FORT WORTH, Texas, Aug. 28, 2026 (GLOBE NEWSWIRE) -- RANGE RESOURCES CORPORATION (NYSE: RRC) today announced that its Board of Directors dec
Netcapital Inc. Announces Receipt of Nasdaq Notification Regarding Delayed Annual Report on Form 10-K
BOSTON, Massachusetts, Aug. 28, 2026 (GLOBE NEWSWIRE) -- Netcapital Inc. (Nasdaq: NCPL) (the “Company”) today announced that on August 24, 2
Jiayin Group Inc. Reports Second Quarter 2026 Unaudited Financial Results
SHANGHAI, Aug. 28, 2026 (GLOBE NEWSWIRE) -- Jiayin Group Inc. (“Jiayin” or the “Company”) (NASDAQ: JFIN), a leading fintech platform in Chin
NVRO Metals Advances Commercial Deployment of the NVRO Process™ Through Successful Continuous Production Demonstration on Hecla Greens Creek Material
VANCOUVER, British Columbia, Aug. 28, 2026 (GLOBE NEWSWIRE) -- NVRO Metals Limited (TSXV: NVRO | OTCQB: ESGLF | FSE: YGK) ("NVRO Metals" or
BioXcel Therapeutics Enters Into Asset Sale Agreement with Teva Pharmaceuticals
BioXcel Therapeutics intends to complete a court-supervised sale transaction, in an effort to maximize value for all stakeholders Teva Pharma
Immuron Reports FY26 Preliminary Results
MELBOURNE, Australia, Aug. 28, 2026 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN) is pleased to release its preliminary resul
Quoin Pharmaceuticals Reports Positive Interim Data from Ongoing Phase 2/3 Study of QRX003 in Netherton Syndrome
Interim Analysis of the First Six Patients to Complete 12 Weeks of Treatment Met Pre-Specified Alpha Adjusted Target for Primary Endpoint with
Quoin Pharmaceuticals Announces Private Placement Financing of Up to $50.0 Million
ASHBURN, Va., Aug. 28, 2026 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a late clinical-stage
Cytokinetics Announces Positive Results from ACACIA-HCM Presented in Hot Line Session at the European Society of Cardiology (ESC) Congress 2026 and Published in The New England Journal of Medicine
ACACIA-HCM is the First Phase 3 Clinical Trial to Successfully Demonstrate Statistically Significant Improvements Across Both Patient-Reported
CDT Validates Enhanced Solid-Form Properties Within Its IP Portfolio
NAPLES, Fla. and CAMBRIDGE, United Kingdom, Aug. 28, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), today
GCL Announces $10 Million Share Repurchase Program
SINGAPORE, Aug. 28, 2026 (GLOBE NEWSWIRE) -- GCL Global Holdings Ltd. (Nasdaq: GCL) (“GCL” or the “Company”), a leading provider of games an